Reported Reactions

Devices › Implant, endosseous, root-form

Device brand name · Endosseous dental implant

CI ?4.1mm RD, ZLA 12mm, ZrO2: medical device reports filed with FDA

393 reports name it, 2019–2026. Manufacturer given most often on reports: Institut Straumann. Product code DZE.

393
device reports naming the brand
0% of all MAUDE reports · about 54 a year
24
reports, 12 months to August 2026
30 in the 12 months before
0%
classified as malfunction
0.8% across the product code
0%
classified as death, as reported
0 reports · not verified by FDA

FDA's MAUDE database holds 393 reports that name the brand "CI ?4.1mm RD, ZLA 12mm, ZrO2" (endosseous dental implant), received between March 2019 and July 2026; the manufacturer given most often on reports is Institut Straumann. Spellings of one product vary from report to report.

24 reports arrived in the 12 months to August 2026, down 20% from 30 in the 12 months before. FDA releases MAUDE data monthly; reports can arrive months after an event, so the newest months grow in later releases. The event types recorded are injury (100%); across all implant, endosseous, root-form reports (product code DZE) death is recorded in 0% and malfunction in 0.8%. Event type is the reporter's classification of the report, not a verified outcome.

The device problems coded most often are failure to osseointegrate (65.9%), loss of osseointegration (16.3%) and fracture (5.9%). The patient problems coded most often are fibrosis, pain and tissue damage. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data."

Reports by month, five years

0714Sep 2021: 6Oct 2021: 3Nov 2021: 8Dec 2021: 92022Jan 2022: 7Feb 2022: 8Mar 2022: 4Apr 2022: 3May 2022: 8Jun 2022: 2Jul 2022: 5Aug 2022: 14Sep 2022: 3Oct 2022: 6Nov 2022: 4Dec 2022: 42023Jan 2023: 5Feb 2023: 5Mar 2023: 3Apr 2023: 3May 2023: 0Jun 2023: 3Jul 2023: 6Aug 2023: 6Sep 2023: 8Oct 2023: 5Nov 2023: 9Dec 2023: 92024Jan 2024: 9Feb 2024: 8Mar 2024: 1Apr 2024: 7May 2024: 7Jun 2024: 2Jul 2024: 5Aug 2024: 3Sep 2024: 1Oct 2024: 3Nov 2024: 9Dec 2024: 32025Jan 2025: 2Feb 2025: 1Mar 2025: 1Apr 2025: 2May 2025: 0Jun 2025: 6Jul 2025: 1Aug 2025: 1Sep 2025: 1Oct 2025: 2Nov 2025: 9Dec 2025: 32026Jan 2026: 2Feb 2026: 0Mar 2026: 2Apr 2026: 0May 2026: 1Jun 2026: 1Jul 2026: 3Aug 2026: 0

Reports by the month FDA received them. FDA releases MAUDE data monthly; reports can arrive months after an event, so the newest months grow in later releases.

By year received

035692019: 5120192020: 4720202021: 6920212022: 6820222023: 6220232024: 5820242025: 2920252026: 92026

Event type and report source

Event type, as classified on the report

Death0%0
Injury100%393
Malfunction0%0
Other0%0
Not given0%0

Who filed the report

Manufacturer report87.8%345
Voluntary report0%0
User facility report0%0
Distributor report12.2%48
Not given0%0

Grey bar: all 3,924,241 reports carrying product code DZE. Event type is the filer's classification and is not verified by FDA.

Device problems coded

Device problem (FDA code)ReportsShareShare across product code
Failure to osseointegrate25965.9%62.8%
Loss of osseointegration6416.3%22.4%
Fracturea broken bone235.9%1.6%
Difficult to insertthe device was hard to insert71.8%0.4%
Difficult to removethe device was hard to remove20.5%0%

FDA's device problem codes as entered on the report; one report can carry several. Generic codes such as "no apparent adverse event" are left out.

Patient problems coded

Patient problem (FDA code)ReportsShare
Fibrosis10827.5%
Painpain, site not specified9524.2%
Tissue damage6416.3%
Inflammationinflammation348.7%
Fistula194.8%
Swelling/ edema164.1%
Hemorrhage/blood loss/bleeding143.6%
Abscessa collection of pus123.1%
Hypersensitivity/allergic reaction92.3%
Swellingswelling61.5%
Hyperresponsive to stimuli51.3%
Numbnessnumbness41%
Sinus perforation41%
Inadequate osseointegration30.8%
Failure of implant20.5%

Patient problem codes are present mainly in reports filed since 2019 and are often blank.

In context

MeasureCI ?4.1mm RD, ZLA 12mm, ZrO2Product code DZEAll MAUDE reports
Reports3933,924,24126,136,888
Share of that pool—0%0%
Classified as death, per 1,000 reports009
Classified as injury100%99.2%36.2%
Classified as malfunction0%0.8%62.3%
Filed by the manufacturer87.8%77.7%94.9%

Shares are of reports, not of devices in use. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data."

Other brands with product code DZE

BrandReportsLatest 12 monthsClassified as death
Biohorizons Dental Implant58,73200%
BioHorizons Inc.57,02025,5360%
NobelActive Internal RP 4.3x10mm49,0989,5280%
BLT ?4.1mm RC, SLA? 10mm, TiZr, Loxim45,6509,6770%
NobelParallel CC RP 4.3x10mm44,2699,3180%
BLT ?4.1mm RC, SLActive? 10mm, TiZr, NTP41,6727,5310%
Unknown Implant39,9671,4540%
NobelReplace CC RP 4.3x10mm35,9468,1660%
NobelReplace CC PMC RP 4.3x10mm34,4478,6900%
NobelActive Internal RP 4.3x11.5mm33,1175,7040%
BLT ?3.3mm NC, SLA? 10mm, TiZr, Loxim28,6485,6950%
BLT ?4.1mm RC, SLA? 10mm, Ti, Loxim26,7248,4810%
BLT ?3.3mm NC, SLActive? 10mm, TiZr, NTP26,5404,6800%
NobelActive Internal RP 4.3x13mm25,5563,7640%
BLT ?4.1mm RC, SLA? 8mm, TiZr, Loxim24,7725,9780%

Ordered by report count for navigation only. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data." FDA also states that "common products may have a higher number of adverse events due to the higher total number of people using the product."

Questions about CI ?4.1mm RD, ZLA 12mm, ZrO2 reports

How many FDA reports name CI ?4.1mm RD, ZLA 12mm, ZrO2?

393 medical device reports in the openFDA MAUDE release of 28 Sep 2026, covering reports received through August 2026; 24 in the latest 12 months.

What kinds of events are reported?

injury (100%). "Event type" is how the report was classified when filed: death, injury, malfunction or other.

What device problems are coded?

failure to osseointegrate (65.9%), loss of osseointegration (16.3%), fracture (5.9%), difficult to insert (1.8%) and difficult to remove (0.5%). These are FDA's device problem codes as entered on the report.

Who files these reports?

manufacturer reports (87.8%) and distributor reports (12.2%). Manufacturers and user facilities are required to report; voluntary reports come from health professionals and the public.

Do these reports show that CI ?4.1mm RD, ZLA 12mm, ZrO2 was at fault?

No. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data." FDA adds that "a causal relationship cannot be established between product and reactions listed in a report."

How do I report a problem with a medical device?

Through FDA MedWatch (Form FDA 3500 for health professionals and consumers), or to the manufacturer. See the guide on how to report.

Where this comes from. Counts are built from the openFDA Device Adverse Event (MAUDE) bulk export released 28 Sep 2026, which holds reports FDA received through 31 Aug 2026. Brand, generic and manufacturer names are as written on the reports; product code names come from FDA's device classification. A report counts here when any device it lists carries this brand name after punctuation and capitalisation are normalised. No report narrative, lot number, patient detail or reporter identity is published. See the methodology and sources; FDA's record is authoritative, and corrections are handled within five working days.

Drug data (FAERS) through 30 Jun 2026; device data (MAUDE) through 31 Aug 2026. Not medical advice.